Tvardi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVRD and other ETFs, options, and stocks.About TVRD
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
TVRD Key Statistics
Stock Snapshot
The current Tvardi Therapeutics(TVRD) stock price is $0.85, with a market capitalization of 11.62M. The stock trades at a price-to-earnings (P/E) ratio of -0.30.
During the trading session on 2026-10-27, Tvardi Therapeutics(TVRD) shares reached a daily high of $0.91 and a low of $0.83. At a current price of $0.85, the stock is +2.3% higher than the low and still -6.4% under the high.
Trading activity shows a volume of 72.69K, compared to an average daily volume of 117.31K.
The stock's 52-week range extends from a low of $0.83 to a high of $5.69.
The stock's 52-week range extends from a low of $0.83 to a high of $5.69.
Analyst ratings
80%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.